TSHA EBITDA Growth
Taysha Gene Therapies Inc · EBITDA Growth
TSHA EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-62.75%period ending
TSHA TTM EBITDA YoY % (-230.62% → -62.75%)
Year-over-year change
High-resolution chart · PNG
TSHA ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -62.747% | |
| -51.077% | |
| -23.0776% | |
| -377.4865% | |
| 17.4003% | |
| 24.3532% | |
| 16.394% | |
| 90.0892% | |
| 6.5132% | |
| 12.2281% | |
| 35.1421% | |
| -32.7529% | |
| 35.0599% | |
| 32.247% | |
| 6.0294% | |
| -11.0939% | |
| -72.1169% | |
| -119.4912% | |
| -187.7964% | |
| -230.6193% |